Proxima CRO
5
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Clinical Validation Study of the Eximis CS (Contained Segmentation) System
Role: collaborator
Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.
Role: collaborator
Safe Surveillance of PCI Under Mechanical Circulatory Support With the Saranas Early Bird Bleed Monitoring System
Role: collaborator
Signal Relief Patch in Musculoskeletal Pain
Role: collaborator
Safety and Accuracy of the Saranas EBBMS for the Detection of Endovascular Procedure Related Bleeding Events
Role: collaborator
All 5 trials loaded